Noticias de investigación
Ver artículos por meses y años
1–9 of 9 artículos
-
Drug May Boost Survival in Metastatic Breast Cancer (en inglés)
Women diagnosed with metastatic breast cancer that had stopped responding or failed to respond to other treatments lived 2 months longer when treated with Halavan (chemical name: eribulin) compared to ...
-
FDA Approves Drug for Pretreated Breast Cancer (en inglés)
The U.S. Food and Drug Administration (FDA) has approved a new chemotherapy medicine, Halaven (chemical name: eribulin), to treat metastatic breast cancer that already has been treated with other chemo...
-
ASE: Early Echo Predicts Heart Damage in Breast CA Therapy (en inglés)
A study suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional tests.
-
Modest Antitumor Effects with Bisphosphonate (en inglés)
Zometa (chemical name: zoledronic acid) is a medicine used to strengthen bones in women diagnosed with breast cancer that has spread to the bone. Zometa can reduce bone pain and the risk of broken bone...
-
Sequential Docetaxel: No Benefit in Early Breast Cancer (en inglés)
The chemotherapy medicine Taxotere (chemical name: docetaxel) is approved to be used in combination with other chemotherapy medicines to treat early-stage breast cancer. Still, doctors continued to stu...
-
TOP2A Gene Change Affects Response in Breast Cancer (en inglés)
Genes in breast cancer cells affect how the cancer grows and how it responds to certain treatments. A study found that HER2-negative breast cancers are usually topo II-negative. This means that the can...
-
New Chemotherapy Agents Cut Advanced Breast Cancer Mortality in Half (en inglés)
Research has made it clear that new ways to treat and diagnose breast cancer have benefitted women diagnosed with early-stage breast cancer. Women diagnosed with advanced-stage breast cancer also have ...
-
ASCO Breast: Low-Dose, Rapid-Cycle Chemotherapy Active Against Anthracycline-Resistant Disease (en inglés)
Adriamycin (chemical name: doxorubicin) and Ellence (chemical name: epirubicin) are both anthracyclines, a type of chemotherapy medicine. Anthracyclines often are used to treat advanced-stage breast ca...
-
Paclitaxel improves early breast cancer survival (en inglés)
A large study looked at more than 1,200 women who had surgery to treat early-stage breast cancer that had spread to nearby lymph nodes. After surgery, all of the women got a particular combination of c...
1–9 of 9 artículos
